Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.” ...

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...